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Abstract
Background: Nocturnal eating have recently increased. Serum phosphorus levels and regulators of phosphorus have
circadian variations, so it is suggested that the timing of eating may be important in controlling serum phosphorus
levels. However, there have been no reports on the effects of nocturnal eating on phosphorus metabolism.
The objective was to evaluate the effects of nocturnal eating on phosphorus metabolism.
Methods: Fourteen healthy men participated in two experimental protocols with differing dinner times. The design of
this study was a crossover study. The subjects were served test meals three times (breakfast; 07:30 h, lunch; 12:30 h,
dinner; 17:30 or 22:30 h) a day. Blood and urine samples were collected to assess diurnal variation until the following
morning.
Results: The following morning, fasting serum phosphorus levels in the late dinner group were markedly higher than
those in the early dinner group (p < 0.001), although serum calcium levels were maintained at approximately constant
levels throughout the day in both groups. Fluctuations in urinary calcium excretion were synchronized with the timing
of dinner eating, however, fluctuations in urinary phosphorus excretion were not synchronized. Urinary phosphorus
excretions at night were inhibited in the late dinner group. In the late dinner group, intact parathyroid hormone levels
didn’t decrease, and they were significantly higher in this group compared with the early dinner group at 20:00 h
(p = 0.004). The following morning, fasting serum fibroblast growth factor 23 levels in the late dinner group had not
changed, but those in the early dinner group were significantly increased (p = 0.003). Serum free fatty acid levels before
dinner were significantly higher in the late dinner group compared with the early dinner group.
Conclusions: Our results indicate that nocturnal eating inhibits phosphorus excretion. It is suggested that nocturnal
eating should be abstained from to manage serum phosphorus levels to within an adequate range.
Keywords: Hyperphosphatemia, Nocturnal eating, Parathyroid hormone, Fibroblast growth factor 23, Free fatty acid
Background
Phosphorus is essential for multiple and diverse bio-
logical functions, including cellular signal transduction,
mineral metabolism, and energy exchange [1]. Serum
phosphorus levels are maintained within a narrow range
(2.5 to 4.5 mg/dL) through a complex interplay between
intestinal absorption and renal excretion of phosphorus
[1–3]. The progressive deterioration of renal function in
chronic kidney disease leads to the retention of many
substances, including phosphorus and increasing serum
phosphorus levels [4]. Elevated serum phosphorus levels
induces vascular calcification, arterial sclerosis and car-
diovascular diseases [5–7] and has been associated with
mortality in dialysis patients [8, 9]. In addition, high
phosphate intake may produce detrimental health effects
in the general public. There is evidence suggesting that
high phosphorus intake and hyperphosphatemia may
contribute to cardiovascular events among individuals
with normal renal function [10–12]. Previous studies
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have also indicated that a high dietary phosphorus intake
increases serum phosphorus levels and impairs endothe-
lial function in healthy individuals [13, 14]. Therefore, it
is recommended that not only patients with renal failure
but also healthy individuals should manage their serum
phosphorus levels within the appropriate range.
Nocturnal eating have recently increased due to shift
work or cluttered lifestyle. According to the national
health and nutrition survey in Japan, 2008, proportion of
those who consume the dinner after 21:00 in over
15 years of age was 11.7 % and was increasing yearly
[15]. Several studies have found a detrimental effect of
night eating on a number of metabolic and cardiovascu-
lar parameters [16, 17], and rotating shift workers exhib-
ited increased risk markers of metabolic syndrome and
inflammation [18]. There has been growing evidence
that when we eat is equally important to health as what
we eat. Recently, the effectiveness of pharmacological
and dietetic therapies appropriate to circadian rhythm
was demonstrated [19, 20]. Previous studies reported
that there are circadian variations in serum phosphorus
levels that they are lowest in the morning and highest in
the middle of the night [21], and also regulators of phos-
phorus such as PTH and FGF23 have circadian rhythm
[21–23]. Therefore, it is suggested that the timing of eat-
ing may be important in controlling serum phosphorus
levels. However, there have been no reports on the effects
of nocturnal eating on phosphorus metabolism.
The purpose of this study was to evaluate the effects




Fourteen healthy men (Body mass index (BMI) 18.5-
25.0 kg/m2) were recruited in this study. Exclusion
criteria included renal dysfunction, apparent health
problems and medication. Renal function and other ap-
parent health problems were checked by a blood test.
Medication was issued verbal confirmation. The study
was performed after obtaining written informed consent
from all of the subjects, and was approved by the Ethics
Committee of the University of Shizuoka. The protocol
conformed to the Helsinki Declaration.
Study protocol
Subjects participated in two experimental protocols with
differing dinner times (Early dinner: Early-D and Late
dinner: Late-D). The design of this experiment was a
crossover study. The experiment was conducted so that
each test day was separated by a washout period of at
least 7 days. Outline of this study is shown in Fig. 1. The
dinner time of Early-D and Late-D were 17:30 h and
22:30 h, respectively. Before each study day, all subjects
were asked to avoid heavy exercise and intake of alcohol,
and they were asked to abstain from foods and beverages
other than appointed phosphorus free water after
14:30 h. Prescribed foods were served at 18:30 h. After
an overnight fast, subjects visited the testing laboratory
at 07:15 h and were asked to void. Fasting venous blood
samples were collected at 07:30 h. Blood samples were
collected immediately before (fasting; 07:30 h) and at
10:00, 12:30, 15:00, 17:30, 20:00, 22:30 h and next morn-
ing at 07:30 h. Subjects were served three test meals
(breakfast; 07:30 h, lunch; 12:30 h and dinner; 17:30 h
(Early-D) or 22:30 h (Late-D)) a day, and they consumed
test meals after blood collection. All subjects drank the
appointed phosphorus free water, 100 ml/h, during the
experimental period. During the experimental period,
subjects were asked to abstain from foods and beverages
other than test meals and appointed phosphorus free
water. Urine samples were collected four times over the
twenty four hours: between 07:30 and 12:30 h (morning);
12:30 and 17:30 h (afternoon); 17:30 and 22:30 h (evening);
and 22:30 and 07:30 h, the following morning (night). Sub-
jects were instructed to go to bed by 24:00. We confirmed
verbally that it was not different in the sleep of time
between Early-D and Late-D.
Test meals
The same constitution test meal was used for the dinner
before the test day, and for breakfast, lunch and dinner
on the test day (total of 4 times). The test meal consisted
of 300 g steamed rice, 55 g boiled egg, 35 g ham, 150 g
milk, and 2 g rice seasoning (666 kcal, 24.2 g protein,
13.8 g fat, 111.8 g carbohydrate, 400 mg phosphorus,
215 mg calcium, and 870 mg sodium). Subjects were
asked to consume the test meal within 20 min. Test
meal components were analyzed by the Japan food
research laboratories foundation (Tokyo, Japan).
Blood and urine analysis methods and anthropometric
measurements
Serum samples were separated and stored at −30 °C until
analyses of serum phosphorus, calcium, creatinine, intact
parathyroid hormone (iPTH) and free fatty acid (FFA)
levels were performed. Urine samples were used for ana-
lysis of phosphorus, calcium, and creatinine levels. The
analysis of serum and urine samples was conducted by the
blood analysis company, SRL Inc (Tokyo, Japan). Serum
samples at 07:30 h and the following 07:30 h were used
for analysis of serum fibroblast growth factor 23 (FGF23)
levels. FGF23 can be processed by a protease to release a
small C-terminal peptide which may complicate the evalu-
ation of intact FGF23 (iFGF23) [24]. Burnett SM et al.
found that iFGF23 reflects the physiological response
more precisely than C-terminal FGF23 [25]. Therefore, we
used an iFGF23 kit for this investigation. Anthropometric
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measurements were determined using a bioelectrical im-
pedance analysis method (TANITA-RBF-215; TANITA
Corporation, Tokyo, Japan). Height was measured with a
stadiometer.
Calculating formulas
We calculated the creatinine clearance (CCr), filtered
phosphorus load (F-Pi), tubular threshold for phos-
phorus (Tp/CCr), urinary phosphorus excretion per
hour (U-Pi/h) and renal fractional phosphorus excretion
(FE-Pi) using the following formulas [26]. (U denotes
urine, S denotes serum, P denotes phosphorus)
CCr ¼ U‐volume U‐Cre=S‐Cre min
F‐Pi ¼ CCr S‐Pi
Tp=CCr ¼ SPiðUPi SCre=UCreÞ
U‐Pi=h ¼ U‐Pi=hour
FE‐Pi ¼ U‐Pi S‐Cre=U‐Cre S‐Pið Þ  100
We also calculated the filtered calcium load (F-Ca),
tubular threshold for calcium (TCa/CCr), urinary cal-
cium excretion per hour (U-Ca/h) and renal fractional
calcium excretion (FE-Ca) using the following formulas.
F‐Ca ¼ CCr S‐Ca
TCa=CCr ¼ SCaðUCa SCre=UCreÞ
U‐Ca=h ¼ U‐Ca=hour
FE‐Ca ¼ U‐Ca S‐Cre=U‐Cre S‐Cað Þ  100
Statistical analysis
Data are shown as mean ± SD, and a P value less than 0.05
was regarded as significant. The Shapiro-Wilk statistic was
performed for testing normality. Parametric analysis was
used for normal distribution data, and non-parametric ana-
lysis was used for non-normal distribution data. Differ-
ences between Early-D and Late-D were calculated using
the Student’s t-test for paired comparisons or Wilcoxon
signed-rank test. Differences from baseline were calculated
using a repeated measure ANOVA or Friedman's Test with
Bonferroni post hoc test. All of the statistical analyses were
performed using the Statistical Package of Social Science
(SPSS for Windows, version 19.0, SPSS, Chicago, IL).
Results
Characteristics of the subjects
The clinical and biological characteristics of the subjects
are shown in Table 1. The mean values ± SD of age and
BMI were 22.8 ± 1.8 years and 22.5 ± 2.2 kg/m2, respect-
ively. Their glucose metabolism, hepatic function and
renal function were normal.
Serum phosphorus, calcium and iPTH levels
The circadian variations in serum phosphorus, calcium
and iPTH levels are shown in Fig. 2. In Early-D and
Late-D, serum phosphorus levels slightly decreased after
Table 1 Characteristics of the subjects
Characteristic Mean ± SD
Age (year) 22.8 ± 1.8
Height (cm) 170.0 ± 5.8
Body weight (kg) 64.9 ± 8.7
Body fat percentage (%) 18.4 ± 3.6
BMI (kg/m2) 22.5 ± 2.2
Triglyceride (mg/dL) 69.7 ± 22.0
LDL-cho (mg/dL) 81.8 ± 15.7
HDL-cho (mg/dL) 60.0 ± 11.4
HbA1c (%) 5.3 ± 0.3
Total protein (g/dL) 7.3 ± 0.4
Albumin (g/dL) 4.8 ± 0.3
UN (mg/dL) 11.6 ± 2.4
Creatinine (mg/dL) 0.9 ± 0.1
Na (mEq/L) 140.2 ± 1.2
K (mEq/L) 4.2 ± 0.1
Ca (mg/dL) 9.6 ± 0.4
Pi (mg/dL) 4.0 ± 0.5
intact PTH (pg/dL) 39.4 ± 11.6
All values are mean ± SD; n = 14. BMI: body mass index; LDL-cho: low density
lipoprotein-cholesterol; HDH-cho: high density lipoprotein-cholesterol;
HbA1c: hemoglobin A1c; UN: urea nitrogen; Na: sodium; K: potassium; Ca: calcium;
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Fig. 1 Schema of this study
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breakfast, and then increased over time. Serum phos-
phorus levels at 12:30, 15:00, 17:30, 20:00 and 22:30 h were
significantly higher than baseline in Early-D (P = 0.037;
12:30 h, P < 0.001; 15:00, 17:30, 20:00 and 22:30 h). In
Late-D, serum phosphorus levels at 15:00, 17:30, 20:00 h
and following morning at 07:30 h were significantly higher
than baseline (P < 0.001; 15:00, 17:30 h and following
morning at 07:30 h, P = 0.005; 20:00 h). Serum phosphorus
levels at 22:30 h in Late-D were significantly lower com-
pared with those in Early-D (P < 0.001) because Late-D
had not yet consumed dinner. The following morning at
07:30 h, fasting serum phosphorus levels in Late-D were
markedly higher than in Early-D (Early-D; 4.0 ± 0.4 mg/dL,
Late-D; 5.0 ± 0.5 mg/dL; P < 0.001) (Fig. 2a).
Serum calcium levels were maintained at approxi-
mately constant levels throughout the day in Early-D
and Late-D (Fig. 2b).
In Early-D, iPTH levels were decreased 2.5 h after
each meal (10:00, 15:00 and 20:00 h) and increased be-
fore each meal (12:30, 17:30 and 22:30 h). In Late-D,
iPTH levels did not decrease at 20:00 h because of con-
tinued fasting to 22:30 h, and were significantly higher
in Late-D compared with Early-D at 20:00 h (P = 0.004)
(Fig. 2c).
Renal phosphorus metabolic indices
The time course of renal phosphorus metabolic indices is
shown in Fig. 3. There were no differences in filtered
phosphorus load (F-Pi) between the Early-D and Late-D
groups at the morning and afternoon measurements,
however, F-Pi at the evening measurement was signifi-
cantly higher in Early-D compared with Late-D (P < 0.001)
and F-Pi at the night measurement was significantly
higher in Late-D than in Early-D (P = 0.019). F-Pi
fluctuated in synchronization with the timing of meals
(Fig. 3a). In addition, fluctuations in the tubular threshold
for phosphorus (Tp/CCr) were synchronized with the
timing of meals, Tp/CCr at the evening measurement
was significantly higher in Early-D compared with
Late-D (P < 0.001) and Tp/CCr at the night measurement
was significantly higher in Late-D compared with Early-D
(P < 0.001) (Fig. 3b). Urinary phosphorus excretion per




Fig. 2 Change in serum phosphorus, calcium and iPTH levels. Open
circle: Early-D; closed square: Late-D. (a) serum phosphorus levels,
(b) serum calcium levels, (c) serum iPTH levels. Differences between
Early-D and Late-D were calculated using the Student’s t-test for
paired comparisons or Wilcoxon signed-rank test. Differences from
baseline were calculated using a repeated measure ANOVA or
Friedman's Test with Bonferroni post hoc test. Early-D: early dinner;
Late-D: late dinner; iPTH: intact parathyroid hormone. *P < 0.001,
**P < 0.01, ***P < 0.05 Early-D versus Late-D. §P < 0.001, §§§P < 0.05
versus baseline for Early-D. †P < 0.001, ††P < 0.01 versus baseline
for Late-D
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significantly lower in Late-D compared with Early-D (P <
0.001) and there was no difference in U-Pi/h at the night
measurement between Early-D and Late-D (Early-D;
34.5 ± 5.6 mg/h, Late-D; 32.9 ± 10.3 mg/h; P = 0.149)
(Fig. 3c). Renal fractional phosphorus excretion (FE-Pi) at
the night measurement was also significantly lower in
Late-D compared with Early-D (P = 0.004) (Fig. 3d). 24-h
total urinary phosphorus excretion was significantly lower
in Late-D than those in Early-D (Early-D; 919.3 ± 97.4 mg,
Late-D; 835.0 ± 129.4 mg; P = 0.043).
Renal calcium metabolic indices
The time course of renal calcium metabolic indices is
shown in Fig. 4. Filtered calcium load (F-Ca) slightly in-
creased during the diurnal period. Although F-Ca at the
evening measurement was significantly higher in Early-D
compared with Late-D (P = 0.007), there was little differ-
ence between Early-D and Late-D (Fig. 4a). The tubular
threshold for calcium (TCa/CCr) was maintained at
approximately constant levels throughout the day in
Early-D and Late-D (Fig. 4b). Urinary calcium excretion
per hour (U-Ca/h) and renal fractional calcium excretion
(FE-Ca) at the evening measurements were significantly
higher in Early-D compared with Late-D (P < 0.001) and at
the night measurements, they were significantly higher in
Late-D compared with Early-D (P < 0.001). Fluctuations in
U-Ca/h and FE-Ca were synchronized with the timing of
meals, unlike U-Pi/h and FE-Pi (Fig. 4c, d). 24-h total urin-
ary calcium excretion was not significantly different be-
tween in Late-D and in Early-D (Early-D; 158.6 ± 46.9 mg,
Late-D; 155.7 ± 52.1 mg; P = 0.713).
Serum FGF-23 levels
On day 1, there were no differences in fasting serum
FGF23 levels between Early-D and Late-D (Early-D;
44.5 ± 13.9 pg/mL, Late-D; 46.7 ± 13.3 pg/mL; P = 0.603).
There were no differences in fasting serum FGF23 levels
in Late-D between day 1 and day 2 (day 1; 46.7 ±
13.3 pg/mL, day 2; 47.7 ± 14.4 pg/mL; P = 0.682). How-
ever, in Early-D, fasting serum FGF23 levels were signifi-
cantly higher on day 2 compared with day 1 (day 1; 44.5 ±
13.9 pg/mL, day 2; 53.1 ± 14.9 pg/mL; P = 0.003) (Table 2).
Serum FFA levels
Serum FFA levels decreased 2.5 h after a meal and in-
creased 5 h after a meal (breakfast, lunch and dinner).
a b
c d
Fig. 3 Time course of renal phosphorus metabolic indices. Open circle: Early-D; closed square: Late-D. (a) filtered phosphorus load (F-Pi), (b)
tubular threshold for phosphorus (Tp/CCr), (c) urinary phosphorus excretion per hour (U-Pi/h), (d) renal fractional phosphorus excretion (FE-Pi).
Differences between Early-D and Late-D were calculated using the Student’s t-test for paired comparisons or Wilcoxon signed-rank test. Differences
from baseline were calculated using a repeated measure ANOVA or Friedman's Test with Bonferroni post hoc test. Early-D: early dinner; Late-D: late
dinner. *P < 0.001, **P < 0.01, ***P < 0.05 Early-D versus Late-D. §P < 0.001, §§§P < 0.05 versus baseline for Early-D. †P < 0.001, ††P < 0.01, †††P < 0.05
versus baseline for Late-D
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Serum FFA levels in Late-D continued rising from 17:30
to 22:30 h. Serum FFA levels at 20:00 and 22:30 h in Late-
D were significantly higher than in Early-D (P < 0.001;
20:00 and 22:30 h). Serum FFA levels before the
evening meal were significantly higher in Late-D
(22:30 h; 648.2 ± 287.3 mEq/L) compared with Early-D
(17:30 h; 328.9 ± 155.5 mEq/L) (p < 0.001) (Fig. 5).
Discussion
In this study, we evaluated the effects of the timing of
the evening meal on phosphorus metabolism. Nocturnal
eating in Late-D caused an increase in serum phos-
phorus levels the following morning (next 07:30 h), and
the serum phosphorus levels exceeded the reference
levels (2.5 to 4.5 mg/dL). Serum phosphorus levels at
22:30 h was above the reference levels in Early-D. This
a b
c d
Fig. 4 Time course of renal calcium metabolic indices. Open circle: Early-D; closed square: Late-D. (a) filtered calcium load (F-Ca), (b) tubular threshold
for calcium (TCa/CCr), (c) urinary calcium excretion per hour (U-Ca/h), (d) renal fractional calcium excretion (FE-Ca). Differences between Early-D and
Late-D were calculated using the Student’s t-test for paired comparisons or Wilcoxon signed-rank test. Differences from baseline were calculated using
a repeated measure ANOVA or Friedman's Test with Bonferroni post hoc test. Early-D: early dinner; Late-D: late dinner. *P < 0.001, **P < 0.01, ***P < 0.05
Early-D versus Late-D. §P < 0.001, §§P < 0.01 versus baseline for Early-D. †P < 0.001, ††P < 0.01 versus baseline for Late-D
Table 2 Serum FGF 23 levels
Day 1 Day 2
Early-D Late-D Early-D Late-D
44.5 ± 13.9 46.7 ± 13.3 53.1 ± 14.9* 47.7 ± 14.4
FGF 23: fibroblast growth factor 23; Early-D: early dinner; Late-D: late dinner
*Significantly different from the Day 1, P = 0.003 (student’s t-test for
paired comparisons)
Fig. 5 Change in serum free fatty acid levels. Open circle: Early-D;
closed square: Late-D. Differences between Early-D and Late-D were
calculated using the Wilcoxon signed-rank test. Differences from
baseline were calculated using a Friedman's Test with Bonferroni
post hoc test. Early-D: early dinner; Late-D: late dinner. *P < 0.001
Early-D versus Late-D. §P < 0.001 versus baseline for Early-D. †P < 0.001,
††P < 0.01, †††P < 0.05 versus baseline for Late-D
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phenomenon is thought to be derived to a circadian
variation of serum phosphorus. Previous study reported
that serum phosphorus levels were lowest in the morn-
ing and highest in the middle of the night, and they were
greatly modified to the reference levels during a pro-
longed fast [21]. If the serum phosphorus levels in the
morning are higher than the reference value such as
Late-D in this study, there is a possibility that the serum
phosphorus levels in the afternoon and the middle of
the night further rises due to the diurnal variation. As a
result, It might be manifested the hyperphosphatemia
throughout the day. Also, considering there were 9 h be-
tween the measurements, serum phosphorus levels were
estimated to be higher at midnight than levels at 07:30 h
the following morning in Late-D. There are four major
possible reasons for the observed serum phosphorus
levels. First, the effect of PTH was considered. PTH in-
creases urinary excretion of phosphorus by lowering renal
sodium-phosphate transporter (NaPi-2a and NaPi-2c) ex-
pression [27]. In addition, PTH stimulates calcium release
from bone and intestinal absorption of calcium by elevat-
ing renal production of 1, 25-OH2D3 [28]. Secretion of
PTH is induced by lowering serum calcium levels [29] and
diminished by increasing serum calcium levels (including
through feeding) [30]. PTH circadian rhythmicity is well
established in healthy individuals, and there is increasing
evidence that fluctuations in PTH secretion may have an
important effect in governing normal bone health, bone
turnover, and bone remodeling [21, 31–34]. It is re-
ported that serum PTH levels gradually increase from
20:00 h, and reach maximum levels between 02:00 and
04:00 h [21, 22]. In Late-D, eating dinner at 22:30 h
raised serum calcium levels at the time of ordinary in-
creasing PTH levels, consequently, PTH secretion in
the middle of the night might be prevented. As a result,
it is possible that serum phosphorus levels were
increased the next morning in Late-D because phos-
phorus excretion during the middle of the night was
inhibited. In this study, U-Pi/h increased after dinner in
Early-D (evening), but did not increase after dinner in
Late-D (night), supporting our hypothesis that noctur-
nal eating inhibits phosphorus excretion during the
middle of the night. The fact that 24-h total urinary
phosphorus excretion in Late-D was significantly lower
than those in Early-D also supports our hypothesis. The
possibility that low serum phosphorus level at 22:30 in
Late-D increased tubular phosphorus reabsorption to
approximate ideal serum phosphorus levels is thought.
Alternately, U-Ca/h increased after dinner in both
Early-D and Late-D, and there were no differences in
serum calcium levels between Early-D and Late-D the
following morning. Calcitonin and PTH are serum
calcium level-regulating hormones. A previous study
indicated that neither increased dietary calcium nor
calcium supplements affected plasma calcitonin re-
sponses [35], therefore it would be necessary to sup-
press PTH secretion in the middle of the night in Late-
D to keep serum calcium levels in the normal range.
Calcium sensing receptors play a crucial role in detect-
ing extracellular calcium levels and initiating the syn-
thesis and secretion of PTH, which is suppressed when
the extracellular calcium concentration is increased
[36]. Serum calcium levels are maintained within a very
narrow range (8.4 to 10.0 mg/dL; 2.1 to 2.5 mmol/L)
compared to serum phosphorus levels (2.5 to 4.5 mg/
dL; 0.8 to 1.6 mmol/L). It is thought that PTH prefer-
entially regulated calcium rather than phosphorus in
this study.
The second possible factor affecting serum phos-
phorus levels may be the effects of FFA. High levels of
serum FFA may contribute to insulin resistance, in-
creased hepatic glucose production [37, 38], and reduced
glucose utilization [39, 40]. It was reported in a study
using vascular smooth muscle cell that an insulin resist-
ant state decreased the cellular uptake of phosphorus
[41]. Serum FFA levels before dinner in Late-D (22:30 h;
648.2 ± 287.3 mEq/L) were significantly higher than
those in Early-D (17:30 h; 328.9 ± 155.5 mEq/L). These
results suggest that cellular uptake of phosphorus was
attenuated by insulin resistance while we cannot affirm
because we did not measure plasma glucose and serum
insulin levels. Another study showed that an oral glucose
load that induced hyperglycemia/hyperinsulinemia pro-
moted a significant decline in serum PTH in postmeno-
pausal women [42]. It is possible that temporary insulin
resistance at the dinner time induced rapid elevation in
glucose and insulin levels, and suppressed PTH secre-
tion in Late-D.
The third reason concerns the effects of FGF23. FGF23
is a recently identified molecule involved in the control of
phosphorus homeostasis. FGF23 reduces serum phos-
phorus levels by decreasing renal phosphorus reab-
sorption and intestinal phosphorus absorption [43–48]. In
a previous study, serum FGF23 levels were slightly
decreased up to 8 h after intake of 400 mg phosphorus. A
significant increase in serum FGF23 levels were observed
8 h after intake of 1200 mg phosphorus compared with in-
take of 400 and 800 mg phosphorus, suggesting that it re-
quires a relatively long time to secrete FGF23 after eating
[13]. In this study, the time from dinner intake to the next
morning (fasting blood collection) was 14 h in Early-D
and 9 h in Late-D. Serum FGF23 levels at the next morn-
ing (Day 2) in Late-D were not elevated compared with
Day 1, but those in Early-D were elevated. We suggest it
took more than 9 h before FGF23 was secreted due to the
intake of 400 mg phosphorus per meal.
The fourth possible factor is the effect of growth
hormone (GH), which involves inhibition of renal
Sakuma et al. Nutrition Journal  (2015) 14:106 Page 7 of 9
phosphorus reabsorption and excretion as well as bone
growth and enlargement of organs such as muscle, heart,
liver and kidney. Secretion of GH is stimulated in the
middle of the night and serum GH levels almost coin-
cides with the highest serum phosphate and PTH levels
[21]. It is possible that the secretion of GH increased
before the phosphorus contained in the dinner was
excreted, thus preventing phosphorus excretion in Late-D.
It is reported that the circadian rhythm of serum phos-
phorus levels was affected by feeding time rather than
light–dark cycle [49]. In a previous observation, ingested
diets containing 625 or 2300 mg phosphorus induced
little or no change in morning fasting serum phosphorus
levels in healthy men. In that study, dinner was con-
sumed at 17:15 h [50]. These previous studies support
our observation that it is not only the “amount of
intake” but also the “timing of eating” which plays an im-
portant role in the control of serum phosphorus levels.
In conclusion, our results indicate that nocturnal
eating leads to hyperphosphatemia. It is suggested that
nocturnal eating should be abstained from to manage
serum phosphorus levels to within an adequate range.
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